Adjuvant therapy with locoregional interferon-beta versus surgery alone for resected stage II/III cutaneous melanoma: A multicenter randomized phase III trial (JCOG1309, J-FERON)

Documenti analoghi

• Prognostic impact of the surgical deep margin distance of invasive acral melanoma of the sole: A multi-institutional retrospective study
  di: S. Koizumi, et al.
  Pubblicazione: (2024-01-01)
• Adjuvant therapy with locoregional interferon-beta versus surgery alone for resected stage II/III cutaneous melanoma: A multicenter randomized phase III trial (JCOG1309, J-FERON)
  di: K. Namikawa, et al.
  Pubblicazione: (2026-01-01)
• A retrospective multicenter study on the real-world efficacy of chemotherapy in 204 Japanese patients with advanced extra-mammary Paget's disease
  di: A. Miyashita, et al.
  Pubblicazione: (2024-01-01)
• The clinical utility of comprehensive genomic profiling tests for patients with advanced malignant melanoma in a real-world setting: A retrospective analysis from a single cancer center
  di: Y. Matsui, et al.
  Pubblicazione: (2024-01-01)
• Genomic and transcriptomic analyses of melanoma in Japanese patients reveal candidate biomarkers for immune checkpoint inhibitor responders
  di: T. Kimura, et al.
  Pubblicazione: (2026-01-01)